Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1958816

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1958816

Artificial Intelligence (AI) in Dermatology Diagnosis Market - Strategic Insights and Forecasts (2026-2031)

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The Artificial Intelligence (AI) In Dermatology Diagnosis Market is forecast to grow at a CAGR of 26.0%, reaching USD 814.3 million in 2031 from USD 256.4 million in 2026.

The Artificial Intelligence in Dermatology Diagnosis Market is strategically positioned within the broader digital healthcare and medical imaging ecosystem. Rising incidence of skin disorders and increasing demand for early and accurate diagnosis are reshaping dermatology services. Healthcare systems are adopting AI tools to enhance clinical efficiency and reduce diagnostic errors. Integration of AI with teledermatology platforms supports remote consultations and improves access to specialist care. Government initiatives promoting digital health infrastructure and the growing acceptance of clinical decision support systems further strengthen market momentum. These macro drivers place AI-based dermatology diagnostics at the center of technology-enabled healthcare transformation.

Market Drivers

The market is driven by the growing prevalence of skin cancer, chronic dermatological conditions, and lifestyle-related skin disorders. Healthcare providers seek faster and more reliable diagnostic solutions to manage rising patient volumes. AI algorithms assist in lesion detection and pattern recognition using large image datasets. Expansion of telemedicine increases the need for automated diagnostic support in remote settings. Demand is also supported by the shortage of trained dermatologists in many regions. Continuous advancements in imaging devices and data analytics improve diagnostic accuracy and encourage adoption.

Market Restraints

Data privacy and patient confidentiality remain major concerns due to the use of medical images and personal health information. Regulatory approval processes for AI-based diagnostic tools are complex and time consuming. Limited clinical validation across diverse populations restricts wider trust among practitioners. Integration of AI systems with hospital information systems can be costly and technically challenging. High development and deployment costs may limit adoption among smaller clinics and healthcare centers. These factors constrain the pace of commercialization despite favorable demand conditions.

Technology and Segment Insights

By technology, the market includes machine learning, deep learning, computer vision, and image analytics platforms. Deep learning holds a significant share due to its effectiveness in detecting complex skin lesion patterns. By application, major segments include skin cancer detection, inflammatory disease diagnosis, pigmentation disorder analysis, and clinical decision support. End users consist of hospitals, dermatology clinics, diagnostic laboratories, and telehealth service providers. Regionally, North America and Europe lead adoption due to strong healthcare infrastructure and early acceptance of digital diagnostics. Asia Pacific shows high growth potential driven by large patient populations and expanding telemedicine networks.

Competitive and Strategic Outlook

The competitive landscape is shaped by medical technology companies, AI software developers, and healthcare solution providers. Strategic priorities focus on partnerships with hospitals and dermatology clinics to support clinical deployment. Companies invest in improving algorithm transparency and accuracy through continuous training on larger datasets. Product development emphasizes user-friendly interfaces and integration with imaging equipment. Regulatory compliance and clinical trials remain key differentiators in gaining physician trust. Long-term strategies include cloud-based platforms and subscription models to expand scalability and recurring revenue streams.

The Artificial Intelligence in Dermatology Diagnosis Market shows strong growth prospects supported by rising disease burden and digital health adoption. Technology innovation and telemedicine expansion remain central growth enablers. Regulatory complexity and data security concerns present ongoing challenges. Market evolution will be shaped by application-specific solutions and regional healthcare modernization efforts.

Key Benefits of this Report

  • Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base Year 2025, Forecast Years 2026-2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments
Product Code: KSI061615853

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Standalone AI Systems
  • 5.3. AI-Powered Mobile Apps

6. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Machine Learning
  • 6.3. Deep Learning
  • 6.4. Computer Vision
  • 6.5. Natural Language Processing (NLP)
  • 6.6. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Skin Cancer Diagnosis
  • 7.3. Acne And Rosacea Diagnosis
  • 7.4. Psoriasis Diagnosis
  • 7.5. Eczema Diagnosis
  • 7.6. Hair And Nail Disorders Diagnosis
  • 7.7. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals And Clinics
  • 8.3. Dermatology Clinics and Centers
  • 8.4. Research Institutes and Academic Centers
  • 8.5. Others

9. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. BY End-User
    • 9.2.5. By Country
      • 9.2.5.1. United States
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Technology
    • 9.3.3. By Application
    • 9.3.4. BY End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Technology
    • 9.4.3. By Application
    • 9.4.4. BY End-User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Italy
      • 9.4.5.5. Spain
      • 9.4.5.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Technology
    • 9.5.3. By Application
    • 9.5.4. BY End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Technology
    • 9.6.3. By Application
    • 9.6.4. BY End-User
    • 9.6.5. By Country
      • 9.6.5.1. Japan
      • 9.6.5.2. China
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Indonesia
      • 9.6.5.6. Taiwan
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. 3derm Systems, Inc.
  • 11.2. Aidoc Medical Ltd.
  • 11.3. Aidoc
  • 11.4. Arterys Inc.
  • 11.5. Beijing Infervision Technology Co., Ltd.
  • 11.6. Butterfly Network, Inc.
  • 11.7. Enlitic, Inc.
  • 11.8. Fdna Inc.
  • 11.9. Ibm Corporation
  • 11.10. Mirada Medical Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!